{"transactions":[{"id":4621522,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-09-17T20:47:49.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":false,"shares":201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service."}],"balance_after":605,"derivative":{"underlying":"Common Stock","underlying_shares":201},"source":{"system":"sec-edgar","filing":"0001051578-26-000010","document":"wk-form4_1789678066.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000105157826000010/wk-form4_1789678066.xml","form_type":"4"}},{"id":4621521,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:47:49.000Z","date":"2026-09-15","kind":"exercise","planned":false,"acquired":true,"shares":201,"ownership":{"direct":false,"nature":"By the David E.I. Pyott Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,383 shares previously owned directly that were transferred to the reporting person's trust on May 14, 2026. There was no change in the reporting person's pecuniary interest in the shares."}],"balance_after":9575,"source":{"system":"sec-edgar","filing":"0001051578-26-000010","document":"wk-form4_1789678066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819790/000105157826000010/wk-form4_1789678066.xml","form_type":"4"}},{"id":724648,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-29T20:30:58.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service."}],"balance_after":806,"derivative":{"underlying":"Common Stock","underlying_shares":806},"source":{"system":"sec-edgar","filing":"0001051578-26-000008","document":"wk-form4_1782765056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000105157826000008/wk-form4_1782765056.xml","form_type":"4"}},{"id":724647,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-29T20:30:58.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":2417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":2417,"derivative":{"underlying":"Common Stock","underlying_shares":2417},"source":{"system":"sec-edgar","filing":"0001051578-26-000008","document":"wk-form4_1782765056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000105157826000008/wk-form4_1782765056.xml","form_type":"4"}},{"id":724646,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-29T20:30:58.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":3837,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":3837,"derivative":{"exercise_price":64.34,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":3837},"source":{"system":"sec-edgar","filing":"0001051578-26-000008","document":"wk-form4_1782765056.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000105157826000008/wk-form4_1782765056.xml","form_type":"4"}},{"id":752712,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-06-03T20:25:20.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":false,"shares":3830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025.  The options exercised by the reporting person were due to expire on June 3, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This stock option was fully vested and exercisable as of June 3, 2017."}],"balance_after":0,"derivative":{"exercise_price":70.2,"exercise_date":"2017-06-03","expiration_date":"2026-06-03","underlying":"Common Stock","underlying_shares":3830},"source":{"system":"sec-edgar","filing":"0001178670-26-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000048/form4.xml","form_type":"4"}},{"id":752711,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-03T20:25:20.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":17,"price":302.65,"value":5145.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025.  The options exercised by the reporting person were due to expire on June 3, 2026."}],"balance_after":1582,"source":{"system":"sec-edgar","filing":"0001178670-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000048/form4.xml","form_type":"4"}},{"id":752710,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-03T20:25:20.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":495,"price":300.72,"value":148856.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025.  The options exercised by the reporting person were due to expire on June 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $300.45 to $301.15. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":1599,"source":{"system":"sec-edgar","filing":"0001178670-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000048/form4.xml","form_type":"4"}},{"id":752709,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-03T20:25:20.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1222,"price":299.87,"value":366441.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025.  The options exercised by the reporting person were due to expire on June 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $299.36 to $300.19. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":2094,"source":{"system":"sec-edgar","filing":"0001178670-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000048/form4.xml","form_type":"4"}},{"id":752708,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-03T20:25:20.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1175,"price":298.91,"value":351219.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025.  The options exercised by the reporting person were due to expire on June 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $298.33 to $299.33. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":3316,"source":{"system":"sec-edgar","filing":"0001178670-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000048/form4.xml","form_type":"4"}},{"id":752707,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-03T20:25:20.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":921,"price":297.71,"value":274190.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025.  The options exercised by the reporting person were due to expire on June 3, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $297.31 to $297.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4491,"source":{"system":"sec-edgar","filing":"0001178670-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000048/form4.xml","form_type":"4"}},{"id":752706,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-03T20:25:20.000Z","date":"2026-06-01","kind":"exercise","planned":true,"acquired":true,"shares":3830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on November 12, 2025.  The options exercised by the reporting person were due to expire on June 3, 2026."}],"balance_after":5412,"source":{"system":"sec-edgar","filing":"0001178670-26-000048","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000048/form4.xml","form_type":"4"}},{"id":766595,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-05-22T20:14:57.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":1441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1441,"derivative":{"exercise_price":298.48,"exercise_date":"2027-05-20","expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":1441},"source":{"system":"sec-edgar","filing":"0001178670-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000039/form4.xml","form_type":"4"}},{"id":766594,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-22T20:14:57.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1582,"source":{"system":"sec-edgar","filing":"0001178670-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000117867026000039/form4.xml","form_type":"4"}},{"id":799165,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-04-28T20:23:58.000Z","date":"2026-04-24","kind":"exercise","planned":false,"acquired":false,"shares":1383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested in full on April 24, 2026, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested in full on April 24, 2026, subject to the Reporting Person's continuous service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1383},"source":{"system":"sec-edgar","filing":"0001051578-26-000006","document":"wk-form4_1777407836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000105157826000006/wk-form4_1777407836.xml","form_type":"4"}},{"id":799164,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-28T20:23:58.000Z","date":"2026-04-24","kind":"exercise","planned":false,"acquired":true,"shares":1383,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Company's common stock."}],"balance_after":1383,"source":{"system":"sec-edgar","filing":"0001051578-26-000006","document":"wk-form4_1777407836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000105157826000006/wk-form4_1777407836.xml","form_type":"4"}},{"id":891312,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-02-20T21:35:48.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":3729,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest in three equal annual installments on March 15th of each of 2027, 2028, and 2029, subject to the Reporting Person's continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest in three equal annual installments on March 15th of each of 2027, 2028, and 2029, subject to the Reporting Person's continuous service."}],"balance_after":3729,"derivative":{"underlying":"Common Stock","underlying_shares":3729},"source":{"system":"sec-edgar","filing":"0001051578-26-000004","document":"wk-form4_1771623346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000105157826000004/wk-form4_1771623346.xml","form_type":"4"}},{"id":891311,"issuer":{"id":1836,"kind":"organization","name":"Tarsus Pharmaceuticals, Inc.","symbol":"TARS"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-02-20T21:35:48.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":5893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares will vest in three equal annual installments on February 18th of each of 2027, 2028, and 2029, subject to the Reporting Person's continuous service."}],"balance_after":5893,"derivative":{"exercise_price":63.27,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":5893},"source":{"system":"sec-edgar","filing":"0001051578-26-000004","document":"wk-form4_1771623346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000105157826000004/wk-form4_1771623346.xml","form_type":"4"}},{"id":1118549,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2025-06-10T00:43:25.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on October 1, 2025, January 1, 2026, and April 1, 2026, respectively,  and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 5, 2025 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":30000,"derivative":{"exercise_price":1.61,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001746473-25-000126","document":"wk-form4_1749516194.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000174647325000126/wk-form4_1749516194.xml","form_type":"4"}},{"id":1152668,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-05-12T20:05:27.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":1558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1558,"derivative":{"exercise_price":258.35,"exercise_date":"2026-05-08","expiration_date":"2035-05-08","underlying":"Common Stock","underlying_shares":1558},"source":{"system":"sec-edgar","filing":"0001735276-25-000063","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527625000063/edgardoc.xml","form_type":"4"}},{"id":1152667,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:05:27.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":911,"source":{"system":"sec-edgar","filing":"0001735276-25-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527625000063/edgardoc.xml","form_type":"4"}},{"id":1192576,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-03-25T20:09:47.000Z","date":"2025-03-24","kind":"exercise","planned":true,"acquired":false,"shares":7440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024.  The options exercised and sold by the reporting person were due to expire on December 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was fully vested and exercisable as of December 18, 2016."}],"balance_after":0,"derivative":{"exercise_price":88.95,"expiration_date":"2025-12-18","underlying":"Common Stock","underlying_shares":7440},"source":{"system":"sec-edgar","filing":"0001735276-25-000040","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527625000040/edgardoc.xml","form_type":"4"}},{"id":1192575,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-25T20:09:47.000Z","date":"2025-03-24","kind":"sale","planned":true,"acquired":false,"shares":7440,"price":299,"value":2224560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024.  The options exercised and sold by the reporting person were due to expire on December 18, 2025."}],"balance_after":136,"source":{"system":"sec-edgar","filing":"0001735276-25-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527625000040/edgardoc.xml","form_type":"4"}},{"id":1192574,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-25T20:09:47.000Z","date":"2025-03-24","kind":"exercise","planned":true,"acquired":true,"shares":7440,"price":88.95,"value":661788.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on September 5, 2024.  The options exercised and sold by the reporting person were due to expire on December 18, 2025."}],"balance_after":7576,"source":{"system":"sec-edgar","filing":"0001735276-25-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527625000040/edgardoc.xml","form_type":"4"}},{"id":1469024,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"exercise","planned":true,"acquired":false,"shares":17560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option was fully vested and exercisable as of December 18, 2018."}],"balance_after":7440,"derivative":{"exercise_price":88.95,"expiration_date":"2025-12-18","underlying":"Common Stock","underlying_shares":17560},"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1469023,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"exercise","planned":true,"acquired":false,"shares":7470,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option was fully vested and exercisable as of June 2, 2018."}],"balance_after":3780,"derivative":{"exercise_price":71.99,"exercise_date":"2018-06-02","expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":7470},"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1469022,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"exercise","planned":true,"acquired":false,"shares":7420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was fully vested and exercisable as of June 3, 2017."}],"balance_after":3830,"derivative":{"exercise_price":70.2,"exercise_date":"2017-06-03","expiration_date":"2026-06-03","underlying":"Common Stock","underlying_shares":7420},"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1469021,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":7470,"price":222,"value":1658340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."}],"balance_after":136,"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1469020,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":7420,"price":221,"value":1639820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."}],"balance_after":7606,"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1469019,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"sale","planned":true,"acquired":false,"shares":17560,"price":220,"value":3863200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."}],"balance_after":15026,"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1469018,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"exercise","planned":true,"acquired":true,"shares":7470,"price":71.99,"value":537765.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."}],"balance_after":32586,"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1469017,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"exercise","planned":true,"acquired":true,"shares":7420,"price":70.2,"value":520884.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."}],"balance_after":25116,"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1469016,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-26T20:28:27.000Z","date":"2024-06-24","kind":"exercise","planned":true,"acquired":true,"shares":17560,"price":88.95,"value":1561962.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were made pursuant to a Rule 10b5-1(c) trading plan adopted by the reporting person on August 11, 2023."}],"balance_after":17696,"source":{"system":"sec-edgar","filing":"0001735276-24-000070","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000070/edgardoc.xml","form_type":"4"}},{"id":1477771,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (Right to Buy)","published_at":"2024-06-18T00:16:03.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":26764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 13th, 2024 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 13, 2024 grant date or (ii) the next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":26764,"derivative":{"exercise_price":13.06,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":26764},"source":{"system":"sec-edgar","filing":"0001746473-24-000105","document":"wk-form4_1718669756.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000174647324000105/wk-form4_1718669756.xml","form_type":"4"}},{"id":1504199,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T21:36:34.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":4720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 21, 2024. Price not applicable."}],"balance_after":49750,"source":{"system":"sec-edgar","filing":"0001048477-24-000110","document":"wk-form4_1716500181.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000104847724000110/wk-form4_1716500181.xml","form_type":"4"}},{"id":1509424,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-05-20T20:11:16.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":5228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5228,"derivative":{"exercise_price":151.22,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":5228},"source":{"system":"sec-edgar","filing":"0001735276-24-000055","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527624000055/edgardoc.xml","form_type":"4"}},{"id":1862833,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T21:24:38.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 7th, 2023 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 7th, 2023 grant date, or (ii) the 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting."}],"balance_after":14000,"derivative":{"exercise_price":23.09,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001209191-23-035538","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000120919123035538/doc4.xml","form_type":"4"}},{"id":1880121,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T22:28:22.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":4190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 23, 2023. Price not applicable."}],"balance_after":45030,"source":{"system":"sec-edgar","filing":"0001209191-23-031977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000120919123031977/doc4.xml","form_type":"4"}},{"id":1885431,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2023-05-19T20:06:50.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":3454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":3454,"derivative":{"exercise_price":189.87,"exercise_date":"2024-05-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":3454},"source":{"system":"sec-edgar","filing":"0001735276-23-000068","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527623000068/edgardoc.xml","form_type":"4"}},{"id":1990968,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-27T21:13:02.000Z","date":"2023-02-23","kind":"exercise","acquired":false,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award vested on February 23, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award vested on February 23, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001735276-23-000018","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527623000018/edgardoc.xml","form_type":"4"}},{"id":1990967,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-27T21:13:02.000Z","date":"2023-02-23","kind":"exercise","acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":136,"source":{"system":"sec-edgar","filing":"0001735276-23-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527623000018/edgardoc.xml","form_type":"4"}},{"id":2225961,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T20:22:23.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters beginning October 1st and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 16, 2022 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting."}],"balance_after":15000,"derivative":{"exercise_price":6.8,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-22-013200","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000156761922013200/doc1.xml","form_type":"4"}},{"id":2255606,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T01:32:51.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":4980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 24, 2022.  Price not applicable."}],"balance_after":40840,"source":{"system":"sec-edgar","filing":"0001567619-22-011800","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000156761922011800/doc1.xml","form_type":"4"}},{"id":2262344,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2022-05-20T20:07:59.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":5153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5153,"derivative":{"exercise_price":128.31,"exercise_date":"2023-05-18","expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":5153},"source":{"system":"sec-edgar","filing":"0001735276-22-000055","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527622000055/edgardoc.xml","form_type":"4"}},{"id":2372774,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-25T21:08:34.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ALNY common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":136,"derivative":{"underlying":"Common Stock","underlying_shares":136},"source":{"system":"sec-edgar","filing":"0001735276-22-000028","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527622000028/edgardoc.xml","form_type":"4"}},{"id":2630905,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2021-07-19T20:23:02.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":4032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":4032,"derivative":{"exercise_price":171.95,"exercise_date":"2022-07-15","expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":4032},"source":{"system":"sec-edgar","filing":"0001735276-21-000073","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527621000073/edgardoc.xml","form_type":"4"}},{"id":2648356,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-02T00:14:50.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":13286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter following June 29, 2021 for three calendar quarters and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 29, 2021 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting."}],"balance_after":13286,"derivative":{"exercise_price":28.2,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":13286},"source":{"system":"sec-edgar","filing":"0001209191-21-044628","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000120919121044628/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-30"}},{"id":2650643,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-01T00:49:48.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":13286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter following June 29, 2021 for three calendar quarters and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 29, 2021 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting."}],"balance_after":13286,"derivative":{"exercise_price":28.2,"expiration_date":"2021-06-28","underlying":"Common Stock","underlying_shares":13286},"source":{"system":"sec-edgar","filing":"0001209191-21-044180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000120919121044180/doc4.xml","form_type":"4"}},{"id":2693931,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T00:05:39.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":5120,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 25, 2021.  Price not applicable."}],"balance_after":35860,"source":{"system":"sec-edgar","filing":"0001567619-21-011320","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000156761921011320/doc1.xml","form_type":"4"}},{"id":2908637,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-13T23:15:07.000Z","date":"2021-01-12","kind":"grant","acquired":true,"shares":26573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 12, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":26573,"derivative":{"exercise_price":27.71,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":26573},"source":{"system":"sec-edgar","filing":"0000899243-21-001875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000089924321001875/doc4.xml","form_type":"4"}},{"id":3042873,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-02T01:44:15.000Z","date":"2020-08-31","kind":"purchase","acquired":true,"shares":900,"price":78.8393,"value":70955.37,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is the weighted average price.  The actual purchase price paid ranged from $78.78 to $78.91.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price."}],"balance_after":30740,"source":{"system":"sec-edgar","filing":"0001567619-20-016270","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000156761920016270/doc1.xml","form_type":"4"}},{"id":3042872,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-02T01:44:15.000Z","date":"2020-08-31","kind":"purchase","acquired":true,"shares":11900,"price":78.2151,"value":930759.69,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is the weighted average price.  The actual purchase price paid ranged from $77.78 to $78.76.  The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price."}],"balance_after":29840,"source":{"system":"sec-edgar","filing":"0001567619-20-016270","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000156761920016270/doc1.xml","form_type":"4"}},{"id":3089326,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2020-07-06T20:49:57.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":4581,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4581,"derivative":{"exercise_price":148.77,"exercise_date":"2021-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":4581},"source":{"system":"sec-edgar","filing":"0001735276-20-000074","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527620000074/edgardoc.xml","form_type":"4"}},{"id":3131044,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T22:32:09.000Z","date":"2020-05-27","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on May 27, 2020. Price not applicable."}],"balance_after":17940,"source":{"system":"sec-edgar","filing":"0001567619-20-011373","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000156761920011373/doc1.xml","form_type":"4"}},{"id":3170872,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2019 Director RSU Award","published_at":"2020-04-24T20:26:51.000Z","date":"2020-04-23","kind":"exercise","acquired":false,"shares":1414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Discretionary vesting on last day of Reporting Person's membership on the Issuer's board of directors given service for nearly entire one-year term for which he had been most recently elected."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-05-01","expiration_date":"2020-05-01","underlying":"Common Stock","underlying_shares":1414},"source":{"system":"sec-edgar","filing":"0001127602-20-014435","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760220014435/form4.xml","form_type":"4"}},{"id":3170871,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-24T20:26:51.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":1414,"price":107.56,"value":152089.84,"ownership":{"direct":true},"balance_after":18684,"source":{"system":"sec-edgar","filing":"0001127602-20-014435","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760220014435/form4.xml","form_type":"4"}},{"id":3290380,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2010 Director Stock Option","published_at":"2020-02-05T20:04:01.000Z","date":"2020-02-03","kind":"exercise","acquired":false,"shares":5027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options are exercisable in three cumulative installments of  33% each year beginning on the first anniversary date of the grant, which is the date given ."}],"balance_after":0,"derivative":{"exercise_price":38.18,"exercise_date":"2011-04-22","expiration_date":"2020-04-22","underlying":"Common Stock","underlying_shares":5027},"source":{"system":"sec-edgar","filing":"0001127602-20-003727","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760220003727/form4.xml","form_type":"4"}},{"id":3290379,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-05T20:04:01.000Z","date":"2020-02-03","kind":"sale","acquired":false,"shares":5027,"price":132.72,"value":667183.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $132.67 to $132.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17270,"source":{"system":"sec-edgar","filing":"0001127602-20-003727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760220003727/form4.xml","form_type":"4"}},{"id":3290378,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-02-05T20:04:01.000Z","date":"2020-02-03","kind":"exercise","acquired":true,"shares":5027,"price":38.18,"value":191930.86,"ownership":{"direct":true},"balance_after":22297,"source":{"system":"sec-edgar","filing":"0001127602-20-003727","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760220003727/form4.xml","form_type":"4"}},{"id":3472011,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2019-07-02T20:06:07.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":72.01,"exercise_date":"2020-07-01","expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-19-000063","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527619000063/edgardoc.xml","form_type":"4"}},{"id":3499220,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T21:47:13.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":4430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 4, 2019. Price not applicable."}],"balance_after":13640,"source":{"system":"sec-edgar","filing":"0001567619-19-012958","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000156761919012958/doc1.xml","form_type":"4"}},{"id":3544004,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2019 Director RSU Award","published_at":"2019-05-02T23:38:00.000Z","date":"2019-05-01","kind":"grant","acquired":true,"shares":1414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Avery Dennison Corporation common stock."}],"balance_after":1414,"derivative":{"exercise_price":0,"exercise_date":"2020-05-01","expiration_date":"2020-05-01","underlying":"Common Stock","underlying_shares":1414},"source":{"system":"sec-edgar","filing":"0001127602-19-017138","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760219017138/form4.xml","form_type":"4"}},{"id":3544003,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2018 Director RSU Award","published_at":"2019-05-02T23:38:00.000Z","date":"2019-05-01","kind":"exercise","acquired":false,"shares":1336,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2019-05-01","expiration_date":"2019-05-01","underlying":"Common Stock","underlying_shares":1336},"source":{"system":"sec-edgar","filing":"0001127602-19-017138","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760219017138/form4.xml","form_type":"4"}},{"id":3544002,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2016 Director RSU Award","published_at":"2019-05-02T23:38:00.000Z","date":"2019-05-01","kind":"exercise","acquired":false,"shares":641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares reflect the vesting of the third tranche of restricted stock units granted on May 1, 2016."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2017-05-01","expiration_date":"2019-05-01","underlying":"Common Stock","underlying_shares":641},"source":{"system":"sec-edgar","filing":"0001127602-19-017138","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760219017138/form4.xml","form_type":"4"}},{"id":3544001,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-02T23:38:00.000Z","date":"2019-05-01","kind":"exercise","acquired":true,"shares":1336,"price":109.63,"value":146465.68,"ownership":{"direct":true},"balance_after":17270,"source":{"system":"sec-edgar","filing":"0001127602-19-017138","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760219017138/form4.xml","form_type":"4"}},{"id":3544000,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-02T23:38:00.000Z","date":"2019-05-01","kind":"exercise","acquired":true,"shares":641,"price":109.63,"value":70272.83,"ownership":{"direct":true},"balance_after":15934,"source":{"system":"sec-edgar","filing":"0001127602-19-017138","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760219017138/form4.xml","form_type":"4"}},{"id":3751506,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2009 Director Stock Option","published_at":"2018-11-28T22:01:06.000Z","date":"2018-11-27","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option grant under the Avery Dennison Corporation Director Equity Plan, as amended and restated. Options are exercisable in two cumulative installments of 50% each year beginning on the first anniversary date of the grant, which is the date given."}],"balance_after":0,"derivative":{"exercise_price":20.64,"exercise_date":"2010-02-26","expiration_date":"2019-02-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-18-034613","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218034613/form4.xml","form_type":"4"}},{"id":3751505,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-28T22:01:06.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":2000,"price":93,"value":186000.0,"ownership":{"direct":true},"balance_after":15293,"source":{"system":"sec-edgar","filing":"0001127602-18-034613","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218034613/form4.xml","form_type":"4"}},{"id":3751504,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-28T22:01:06.000Z","date":"2018-11-27","kind":"exercise","acquired":true,"shares":2000,"price":20.64,"value":41280.0,"ownership":{"direct":true},"balance_after":17293,"source":{"system":"sec-edgar","filing":"0001127602-18-034613","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218034613/form4.xml","form_type":"4"}},{"id":3885346,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2018-06-22T20:19:17.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":105.26,"exercise_date":"2019-06-20","expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-18-000031","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000173527618000031/edgardoc.xml","form_type":"4"}},{"id":3902167,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T01:13:56.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 5, 2018. Price not applicable."}],"balance_after":9210,"source":{"system":"sec-edgar","filing":"0001140361-18-027799","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000114036118027799/doc1.xml","form_type":"4"}},{"id":3951514,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2018 Director RSU Award","published_at":"2018-05-02T22:05:37.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":1336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The restricted stock units vest on the first anniversary of the grant date.  Each restricted stock unit represents a contingent right to receive one share of Avery Dennison Corporation common stock."}],"balance_after":1336,"derivative":{"exercise_price":0,"exercise_date":"2019-05-01","expiration_date":"2019-05-01","underlying":"Common Stock","underlying_shares":1336},"source":{"system":"sec-edgar","filing":"0001127602-18-016057","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218016057/form4.xml","form_type":"4"}},{"id":3951513,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2017 Director RSU Award","published_at":"2018-05-02T22:05:37.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":1678,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2018-05-01","expiration_date":"2018-05-01","underlying":"Common Stock","underlying_shares":1678},"source":{"system":"sec-edgar","filing":"0001127602-18-016057","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218016057/form4.xml","form_type":"4"}},{"id":3951512,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2016 Director RSU Award","published_at":"2018-05-02T22:05:37.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares reflect the vesting of the second tranche of restricted stock units granted on May 1, 2016."}],"balance_after":641,"derivative":{"exercise_price":0,"exercise_date":"2017-05-01","expiration_date":"2019-05-01","underlying":"Common Stock","underlying_shares":641},"source":{"system":"sec-edgar","filing":"0001127602-18-016057","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218016057/form4.xml","form_type":"4"}},{"id":3951511,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2015 Director RSU Award","published_at":"2018-05-02T22:05:37.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares reflect the vesting of the third tranche of restricted stock units granted on May 1, 2015."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2016-05-01","expiration_date":"2018-05-01","underlying":"Common Stock","underlying_shares":747},"source":{"system":"sec-edgar","filing":"0001127602-18-016057","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218016057/form4.xml","form_type":"4"}},{"id":3951510,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-02T22:05:37.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":1678,"price":104.8,"value":175854.4,"ownership":{"direct":true},"balance_after":15293,"source":{"system":"sec-edgar","filing":"0001127602-18-016057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218016057/form4.xml","form_type":"4"}},{"id":3951509,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-02T22:05:37.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":641,"price":104.8,"value":67176.8,"ownership":{"direct":true},"balance_after":13615,"source":{"system":"sec-edgar","filing":"0001127602-18-016057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218016057/form4.xml","form_type":"4"}},{"id":3951508,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-02T22:05:37.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":747,"price":104.8,"value":78285.6,"ownership":{"direct":true},"balance_after":12974,"source":{"system":"sec-edgar","filing":"0001127602-18-016057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760218016057/form4.xml","form_type":"4"}},{"id":4222245,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2008 Director Stock Option","published_at":"2017-08-30T22:02:04.000Z","date":"2017-08-30","kind":"exercise","acquired":false,"shares":1702,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":52.115,"exercise_date":"2009-02-28","expiration_date":"2018-02-28","underlying":"Common Stock","underlying_shares":1702},"source":{"system":"sec-edgar","filing":"0001127602-17-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217026731/form4.xml","form_type":"4"}},{"id":4222244,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2008 Director Stock Option","published_at":"2017-08-30T22:02:04.000Z","date":"2017-08-28","kind":"exercise","acquired":false,"shares":298,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1702,"derivative":{"exercise_price":52.115,"exercise_date":"2009-02-28","expiration_date":"2018-02-28","underlying":"Common Stock","underlying_shares":298},"source":{"system":"sec-edgar","filing":"0001127602-17-026731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217026731/form4.xml","form_type":"4"}},{"id":4222243,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-30T22:02:04.000Z","date":"2017-08-30","kind":"sale","acquired":false,"shares":1702,"price":94,"value":159988.0,"ownership":{"direct":true},"balance_after":16303,"source":{"system":"sec-edgar","filing":"0001127602-17-026731","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217026731/form4.xml","form_type":"4"}},{"id":4222242,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-30T22:02:04.000Z","date":"2017-08-30","kind":"exercise","acquired":true,"shares":1702,"price":52.115,"value":88699.73,"ownership":{"direct":true},"balance_after":18005,"source":{"system":"sec-edgar","filing":"0001127602-17-026731","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217026731/form4.xml","form_type":"4"}},{"id":4222241,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-30T22:02:04.000Z","date":"2017-08-28","kind":"sale","acquired":false,"shares":298,"price":94,"value":28012.0,"ownership":{"direct":true},"balance_after":16303,"source":{"system":"sec-edgar","filing":"0001127602-17-026731","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217026731/form4.xml","form_type":"4"}},{"id":4222240,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-08-30T22:02:04.000Z","date":"2017-08-28","kind":"exercise","acquired":true,"shares":298,"price":52.115,"value":15530.27,"ownership":{"direct":true},"balance_after":16601,"source":{"system":"sec-edgar","filing":"0001127602-17-026731","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217026731/form4.xml","form_type":"4"}},{"id":4288694,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy) Common Stock","published_at":"2017-06-08T22:31:07.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":4910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests in full on June 6, 2018."}],"balance_after":4910,"derivative":{"exercise_price":89.6,"exercise_date":"2018-06-06","expiration_date":"2027-06-05","underlying":"Common Stock","underlying_shares":4910},"source":{"system":"sec-edgar","filing":"0001140361-17-024512","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000114036117024512/doc1.xml","form_type":"4"}},{"id":4288693,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-08T22:31:07.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":2050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on June 6, 2017.  Price not applicable."}],"balance_after":4910,"source":{"system":"sec-edgar","filing":"0001140361-17-024512","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000114036117024512/doc1.xml","form_type":"4"}},{"id":4291538,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2017-06-06T20:59:18.000Z","date":"2017-06-02","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11250,"derivative":{"exercise_price":71.99,"exercise_date":"2018-06-02","expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001553878-17-000028","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000155387817000028/edgardoc.xml","form_type":"4"}},{"id":4337379,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2017 Director RSU Award","published_at":"2017-05-03T19:08:19.000Z","date":"2017-05-01","kind":"grant","acquired":true,"shares":1678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The restricted stock units vest on the first anniversary of the grant date.  Each restricted stock unit represents a contingent right to receive  one share of Avery Dennison Corporation common stock."}],"balance_after":1678,"derivative":{"exercise_price":0,"exercise_date":"2018-05-01","expiration_date":"2018-05-01","underlying":"Common Stock","underlying_shares":1678},"source":{"system":"sec-edgar","filing":"0001127602-17-016576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217016576/form4.xml","form_type":"4"}},{"id":4337378,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2016 Director RSU Award","published_at":"2017-05-03T19:08:19.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares reflect the vesting of the first tranche of restricted stock units granted on May 1, 2016."}],"balance_after":1282,"derivative":{"exercise_price":0,"exercise_date":"2017-05-01","expiration_date":"2019-05-01","underlying":"Common Stock","underlying_shares":640},"source":{"system":"sec-edgar","filing":"0001127602-17-016576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217016576/form4.xml","form_type":"4"}},{"id":4337377,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2015 Director RSU Award","published_at":"2017-05-03T19:08:19.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares reflect the vesting of the second tranche of restricted stock units granted on May 1, 2015."}],"balance_after":747,"derivative":{"exercise_price":0,"exercise_date":"2016-05-01","expiration_date":"2018-05-01","underlying":"Common Stock","underlying_shares":746},"source":{"system":"sec-edgar","filing":"0001127602-17-016576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217016576/form4.xml","form_type":"4"}},{"id":4337376,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"2014 Director RSU Award","published_at":"2017-05-03T19:08:19.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares reflect the vesting of the third tranche of restricted stock units granted on May 1, 2014."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2015-05-01","expiration_date":"2017-05-01","underlying":"Common Stock","underlying_shares":859},"source":{"system":"sec-edgar","filing":"0001127602-17-016576","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217016576/form4.xml","form_type":"4"}},{"id":4337375,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-03T19:08:19.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":640,"price":83.42,"value":53388.8,"ownership":{"direct":true},"balance_after":16303,"source":{"system":"sec-edgar","filing":"0001127602-17-016576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217016576/form4.xml","form_type":"4"}},{"id":4337374,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-03T19:08:19.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":746,"price":83.42,"value":62231.32,"ownership":{"direct":true},"balance_after":15663,"source":{"system":"sec-edgar","filing":"0001127602-17-016576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217016576/form4.xml","form_type":"4"}},{"id":4337373,"issuer":{"id":3410,"kind":"organization","name":"Avery Dennison Corp","symbol":"AVY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-03T19:08:19.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":859,"price":83.42,"value":71657.78,"ownership":{"direct":true},"balance_after":14917,"source":{"system":"sec-edgar","filing":"0001127602-17-016576","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/8818/000112760217016576/form4.xml","form_type":"4"}},{"id":4579836,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":34936,"kind":"person","name":"PYOTT DAVID E I","position":1,"cik":"0001051578","reported_name":"PYOTT DAVID E I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-14T20:22:38.000Z","date":"2016-10-13","kind":"purchase","acquired":true,"shares":27900,"price":37.001,"value":1032327.9,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares of ALNY common stock were purchased by the David E I Pyott Trust, of which the reporting person is trustee."}],"balance_after":27900,"source":{"system":"sec-edgar","filing":"0001553878-16-000059","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1051578/000155387816000059/edgardoc.xml","form_type":"4"}}]}